Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

QUEST DIAGNOSTICS URINE COCAINE METABOLITE EIA

K-Number: K062929 · 2006-12-18

ApplicantQuest Diagnostics, Inc.
Decision Date2006-12-18
Product CodeDIO
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

QUEST DIAGNOSTICS URINE COCAINE METABOLITE EIA is the device name listed in this FDA 510(k) record. The listed applicant is Quest Diagnostics, Inc.. It received FDA 510(k) clearance on 2006-12-18 under 510(k) number K062929. The device is classified under product code DIO. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the QUEST DIAGNOSTICS URINE COCAINE METABOLITE EIA?

QUEST DIAGNOSTICS URINE COCAINE METABOLITE EIA is a medical device that received FDA 510(k) clearance on 2006-12-18. The listed applicant is Quest Diagnostics, Inc.. The 510(k) number is K062929.

When did QUEST DIAGNOSTICS URINE COCAINE METABOLITE EIA receive FDA 510(k) clearance?

QUEST DIAGNOSTICS URINE COCAINE METABOLITE EIA received FDA 510(k) clearance on 2006-12-18, under 510(k) number K062929.

Who is the listed applicant for QUEST DIAGNOSTICS URINE COCAINE METABOLITE EIA?

The FDA 510(k) record lists Quest Diagnostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for QUEST DIAGNOSTICS URINE COCAINE METABOLITE EIA?

The FDA product code for QUEST DIAGNOSTICS URINE COCAINE METABOLITE EIA is DIO.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Quest Diagnostics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K080381QUEST DIAGNOSTICS METHAMPHETAMINE MICRO-PLATE EIAK051161QUEST DIAGNOSTICS HAIRCHECK-DT (AMPHETAMINES)K042726QUEST DIAGNOSTICS HAIRCHECK-DT (PCPK042725QUEST DIAGNOSTICS HAIRCHECK-DT (OPIATES)K040257QUEST DIAGNOSTICS HAIRCHECK-DT (THC)K023626AML HAIRCHECK-DT (COCAINE)

View all 7 devices →

Related Devices (Code: DIO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K213211Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test SystemCarolina Liquid Chemistries Corp.K211973DRI Cocaine Metabolite AssayMicrogenics CorporationK191638Pointe Scientific Cocaine Metabolite Enzyme ImmunoassayMedtest DXK181499DRI Cocaine Metabolite AssayMicrogenics CorporationK170293Emit II Plus Cocaine Metabolite AssaySiemens Healthcare Diagnostics, Inc.K163570Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Test System (COCM)Carolina Liquid Chemistries Corporation

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑